Journal of Liver

Zhekang Ying

Publications

• Commentary
  Liver Fibrosis Conventional and Molecular Imaging Diagnosis Update
  Author(s): Shujing Li, Xicui Sun, Minjie Chen, Zhekang Ying, Yamin Wan, Liya Pi, Bin Ren and Qi CaoShujing Li, Xicui Sun, Minjie Chen, Zhekang Ying, Yamin Wan, Liya Pi, Bin Ren and Qi Cao
  
  Liver fibrosis is a serious, life-threatening disease with high morbidity and mortality that result from diverse causes. Liver biopsy, considered the “gold standard” to diagnose, grade, and stage liver fibrosis, has limitations in terms of invasiveness, cost, sampling variability, inter-observer variability, and the dynamic process of fibrosis. Compelling evidence has demonstrated that all stages of fibrosis are reversible if the injury is removed. There is a clear need for safe, effective, and reliable non-invasive assessment modalities to determine liver fibrosis in order to manage it precisely in personalized medicine. However, conventional imaging methods used to assess morphological and structural changes related to liver fibrosis, including ultrasound, computed tomography (CT), and magnetic resonance imaging (MRI), are only useful in assessing advanced liver disease,.. View More»
  DOI: 10.35248/2167-0889.19.8.236

  Abstract PDF